Literature DB >> 20425818

Quality of life in rare genetic conditions: a systematic review of the literature.

Julie S Cohen1, Barbara B Biesecker.   

Abstract

Quality of life (QoL) refers to an individual's sense of overall well-being encompassing physical, psychological, emotional, social, and spiritual dimensions. Although genetics healthcare providers strive to promote patient well-being, and the term QoL is often invoked to refer to this outcome, there is lack of clarity as to what actually constitutes QoL from the patient's perspective. This systematic literature review aims to summarize and integrate research findings to help elucidate how healthcare providers can more effectively enhance the QoL of patients affected with rare genetic conditions. Eligible studies were those that measured QoL as a primary outcome variable using a validated, multi-dimensional scale. Detailed criteria were used to rate quality of design, methodology, and analytic rigor. Fifty-eight studies were selected for inclusion in the review, and a narrative synthesis of the data was performed. A central theme emerging from the literature is that, although genetic conditions have the potential to have significant negative consequences for individuals' lives, having a genetic condition does not necessarily entail poor QoL. Evidence demonstrates that factors beyond the physical manifestations of the disease, such as psychological well-being, coping, and illness perceptions, influence QoL and may serve as potent targets for intervention. The field of research on QoL in rare genetic conditions will be advanced by uniting around a clear conceptualization of QoL and using more rigorous methodology with comprehensive measures of global QoL. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20425818      PMCID: PMC3113481          DOI: 10.1002/ajmg.a.33380

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  80 in total

1.  Assessing health-related quality-of-life in individuals with haemophilia.

Authors:  A H Miners; C A Sabin; K H Tolley; C Jenkinson; P Kind; C A Lee
Journal:  Haemophilia       Date:  1999-11       Impact factor: 4.287

2.  The health status and quality of life of adults with X-linked agammaglobulinemia.

Authors:  Vanessa Howard; Jeffrey M Greene; Savita Pahwa; Jerry A Winkelstein; John M Boyle; Mehmet Kocak; Mary Ellen Conley
Journal:  Clin Immunol       Date:  2005-12-22       Impact factor: 3.969

3.  Self-rated psychosocial consequences and quality of life in the acute porphyrias.

Authors:  L M Millward; P Kelly; A Deacon; V Senior; T J Peters
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

4.  The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.

Authors:  A M Damiano; G M Pastores; J E Ware
Journal:  Qual Life Res       Date:  1998-07       Impact factor: 4.147

5.  Effect of disease-related pain on the health-related quality of life of children and adolescents with cystic fibrosis.

Authors:  Tonya M Palermo; Dale Harrison; Jeffrey L Koh
Journal:  Clin J Pain       Date:  2006 Jul-Aug       Impact factor: 3.442

Review 6.  Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications.

Authors:  Mirella De Civita; Dean Regier; Abul H Alamgir; Aslam H Anis; Mark J Fitzgerald; Carlo A Marra
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 7.  Adaptation to living with a genetic condition or risk: a mini-review.

Authors:  B B Biesecker; L Erby
Journal:  Clin Genet       Date:  2008-09-24       Impact factor: 4.438

8.  Quality of life in patients with Cystic Fibrosis: association with anxiety and depression.

Authors:  Trudy Havermans; Kristine Colpaert; Lieven J Dupont
Journal:  J Cyst Fibros       Date:  2008-08-09       Impact factor: 5.482

9.  Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.

Authors:  P Wolkenstein; D Rodriguez; S Ferkal; H Gravier; V Buret; N Algans; M-C Simeoni; S Bastuji-Garin
Journal:  Br J Dermatol       Date:  2008-12-05       Impact factor: 9.302

10.  Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease.

Authors:  Natalie Jansen Street; Michael S Yi; Laurie A Bailey; Robert J Hopkin
Journal:  Genet Med       Date:  2006-06       Impact factor: 8.822

View more
  58 in total

1.  Health-Related Quality of Life in Patients with MPS II.

Authors:  Mary Needham; Wendy Packman; Natasha Quinn; Maxwell Rappoport; Christa Aoki; Alan Bostrom; Matthew Cordova; Sandra Macias; Cynthia Morgan; Seymour Packman
Journal:  J Genet Couns       Date:  2014-11-14       Impact factor: 2.537

2.  Quality of life and autonomy in emerging adults with early-onset neuromuscular disorders.

Authors:  Darcy J Huismann; Jane P Sheldon; Beverly M Yashar; Kimberly Amburgey; James J Dowling; Elizabeth M Petty
Journal:  J Genet Couns       Date:  2012-02-25       Impact factor: 2.537

3.  Systematic review of quality of life in Turner syndrome.

Authors:  Carolina Trombeta Reis; Maíra Seabra de Assumpção; Gil Guerra-Junior; Sofia Helena Valente de Lemos-Marini
Journal:  Qual Life Res       Date:  2018-02-09       Impact factor: 4.147

4.  Healthcare Coordination and Transition for Individuals with Genetic Conditions.

Authors:  Sharon Romelczyk; Sharon Homan; Joseph Telfair; Gaurav Dave; Alisha Keehn; Deborah Maiese
Journal:  Matern Child Health J       Date:  2015-10

5.  HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.

Authors:  Arlene Smaldone; Sally Findley; Deepa Manwani; Haomiao Jia; Nancy S Green
Journal:  J Pediatr       Date:  2018-03-20       Impact factor: 4.406

Review 6.  Life with a Primary Immune Deficiency: a Systematic Synthesis of the Literature and Proposed Research Agenda.

Authors:  Morgan N Similuk; Angela Wang; Michael J Lenardo; Lori H Erby
Journal:  J Clin Immunol       Date:  2016-02-12       Impact factor: 8.317

7.  Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.

Authors:  J S Cohen; H P Levy; J Sloan; J Dariotis; B B Biesecker
Journal:  Clin Genet       Date:  2015-01-20       Impact factor: 4.438

8.  Factors associated with health-related quality of life (HRQOL) in adults with short stature skeletal dysplasias.

Authors:  Nitasha Dhiman; Alia Albaghdadi; Cheryl K Zogg; Meesha Sharma; Julie E Hoover-Fong; Michael C Ain; Adil H Haider
Journal:  Qual Life Res       Date:  2016-11-19       Impact factor: 4.147

9.  Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome.

Authors:  D J Karas; G Costain; E W C Chow; A S Bassett
Journal:  J Intellect Disabil Res       Date:  2012-10-29

Review 10.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.